C

    Cronos Group Inc (CRON)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $3.37
    -0.01 (-0.30%)

    Market Cap: $1.24B

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    49%(18/37)
    Avg Surprise
    +65.95%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.04
    Range$0.03 - $0.04
    2 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$0.00-100.0%
    60d ago$0.01-80.0%
    30d ago$0.01-80.0%
    7d ago$0.02-40.0%
    Current$0.04
    Revenue Consensus
    $69M
    Range$59M - $75M
    3 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.16
    Range$0.08 - $0.23
    4 analysts
    Revenue Consensus
    $91M
    Range$53M - $110M
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.16---
    Sep 26EST
    		-$0.04---
    Jun 26
    Reported Aug 6
    		$0.03$0.01+200.00%Beat+130.0%
    Mar 26
    Reported May 11
    		$0.05$0.01+400.00%Beat+66.7%
    Dec 25
    Reported Feb 26
    		$-0.00N/A-147.00%Miss-103.0%
    Sep 25
    Reported Nov 6
    		$0.10$0.02+400.00%Beat+233.3%
    Jun 25
    Reported Aug 7
    		$-0.10$-0.02-400.00%Miss-400.0%
    Mar 25
    Reported May 8
    		$0.03$-0.00+957.14%Beat+400.0%
    Dec 24
    Reported Feb 27
    		$0.16$-0.01+1806.45%Beat+417.4%
    Sep 24
    Reported Nov 12
    		$0.03$-0.01+400.00%Beat+250.0%
    Jun 24
    Reported Aug 8
    		$-0.02N/A+71.43%Beat+33.3%
    Mar 24
    Reported May 9
    		$-0.01$-0.01+0.00%Beat+66.7%
    Dec 23
    Reported Feb 29
    		$-0.05$-0.01-400.00%Miss+76.2%
    Sep 23
    Reported Nov 8
    		$-0.02$-0.04+50.00%Beat+77.8%
    Jun 23
    Reported Aug 8
    		$-0.03$-0.05+40.00%Beat+57.1%
    Mar 23
    Reported May 9
    		$-0.03$-0.05+40.00%Beat+72.7%
    Dec 22
    Reported Feb 28
    		$-0.21$-0.05-320.00%Miss-90.9%
    Sep 22
    Reported Nov 7
    		$-0.09$-0.07-28.57%Miss-142.9%
    Jun 22
    Reported Aug 9
    		$-0.07$-0.07+0.00%Beat+50.0%
    Mar 22
    Reported May 10
    		$-0.11$-0.10-10.00%Miss+21.4%
    Dec 21
    Reported Feb 18
    		$-0.11$-0.13+15.38%Beat+64.5%
    Sep 21
    Reported Sep 30
    		$0.21$-0.10+310.00%Beat+261.5%
    Jun 21
    Reported Aug 6
    		$-0.14$-0.08-75.00%Miss-55.6%
    Mar 21
    Reported May 7
    		$-0.14$-0.11-27.27%Miss-40.0%
    Dec 20
    Reported Feb 26
    		$-0.31$-0.07-342.86%Miss-247.6%
    Sep 20
    Reported Nov 5
    		$-0.13$-0.05-160.00%Miss-85.7%
    Jun 20
    Reported Aug 6
    		$-0.09$-0.07-28.57%Miss-125.0%
    Mar 20
    Reported May 8
    		$-0.10$-0.09-11.11%Miss-66.7%
    Dec 19
    Reported Mar 30
    		$0.21$-0.04+625.00%Beat+520.0%
    Sep 19
    Reported Nov 12
    		$-0.07$-0.04-75.00%Miss-75.0%
    Jun 19
    Reported Aug 8
    		$-0.04$-0.02-100.00%Miss-100.0%
    Mar 19
    Reported May 9
    		$-0.06$-0.03-100.00%Miss-500.0%
    Dec 18
    Reported Mar 26
    		$-0.05$0.02-350.00%Miss-400.0%
    Sep 18
    Reported Nov 13
    		$-0.04$-0.02-100.00%Miss-300.0%
    Jun 18
    Reported Aug 14
    		$-0.02$-0.01-100.00%Miss+0.0%
    Mar 18
    Reported May 15
    		$-0.01$-0.01+0.00%Beat-219.0%
    Sep 17
    Reported Nov 29
    		$-0.01$-0.01+0.00%Beat-270.4%
    Jun 17
    Reported Aug 28
    		$-0.01$-0.01+0.00%Beat-
    Mar 17
    Reported May 1
    		$-0.02$-0.01-100.00%Miss-
    Dec 16
    Reported Feb 17
    		$0.01N/AN/ABeat-
    Sep 16
    Reported Nov 30
    		$-0.00N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio19.22EV/EBITDA50.15x
    Price/FCF24.92xFCF Yield4.01%
    Profitability
    Profit Margin39.10%Operating Margin15.40%
    ROE7.05%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio16.18xQuick Ratio15.25x
    Trading Statistics
    Beta1.24Avg Volume1.72M
    52-Week High$3.6152-Week Low$2.28

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$3.36
    SMA 20$3.20
    SMA 50$2.95
    SMA 200$2.72
    EMA 10$3.35
    EMA 20$3.23
    EMA 50$3.03
    EMA 200$2.73

    MACD

    Line: 0.15Signal: 0.14Hist: 0.01

    ADX

    ADX: 31.0+DI: 31.7-DI: 18.2

    Aroon & PSAR

    Aroon Up92.0
    Aroon Down28.0
    PSAR$3.61

    Bollinger Bands

    Upper Band$3.63
    Lower Band$2.78
    %B Position2647%(Upper)
    Band Width0.70

    RSI (14-Day)

    Neutral
    62.9

    Momentum Oscillators

    Stoch %K61.6
    Stoch %D73.2
    Williams %R-41.9
    ROC (10d)7.0%
    Momentum0.22
    CCI (20d)67.0
    MFI (14d)68.8

    Volatility Measures

    ATR (14d)$0.12(3.4%)
    StdDev (20d)0.21
    Hist Vol57.4%(High)

    Volume Flow

    VWAP$3.36
    OBV74.7M
    AD Line-45.9M
    CMF (20d)0.145

    Volume Metrics

    Avg Vol (20d)1.8M
    Vol Ratio0.6x
    VWMA (20d)$3.19

    Pivot Points

    R3$3.54
    R2$3.48
    R1$3.43
    Pivot Point$3.37
    S1$3.32
    S2$3.26
    S3$3.21

    Advanced Oscillators

    TSI35.33
    Ultimate Osc57.1
    KST174.12

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$53.01M$45.21M$32.04M$48.83M$33.45M$32.26M$30.30M$34.26M$27.76M$25.29M$23.91M$24.81M
    Cost of Revenue$24.56M$26.06M$15.85M$30.50M$18.95M$18.53M$19.49M$30.65M$21.46M$20.80M$22.00M$20.84M
    Gross Profit$28.45M$19.15M$16.19M$18.33M$14.50M$13.73M$10.81M$3.61M$6.30M$4.48M$1.91M$3.97M
    Operating Expenses$21.05M$20.99M$23.68M$18.84M$19.83M$17.81M$22.17M$37.27M$21.86M$20.43M$23.55M$25.75M
    R&D$1.22M$1.41M$1.38M$1.34M$929,000$793,000$1.03M$1.24M$962,000$997,000$1.45M$1.25M
    SG&A$10.80M$11.74M$12.90M$9.25M$10.54M$9.31M$12.08M$12.76M$12.77M$8.91M$9.80M$14.37M
    Operating Income$7.40M$-1,833,000$-7,496,000$-503,000$-5,324,000$-4,072,000$-11,365,000$-33,655,000$-15,561,000$-15,948,000$-21,636,000$-21,775,000
    Interest Income$8.82M$8.85M$9.56M$11.74M$9.00M$9.66M$-20,606,000$44.93M$14.37M$15.69M$14.97M$14.43M
    Interest Expense$0$0$4.89M$0$33.68M$0$0$0$0$0$23.88M$0
    Income Before Tax$35.71M$18.14M$-12,386,000$27.00M$-39,007,000$7.27M$45.95M$4.62M$-10,933,000$-3,042,000$-45,511,000$-2,844,000
    Income Tax Expense$51,000$2.43M$-11,895,000$-1,316,000$-525,000$-455,000$2.00M$-2,708,000$-2,174,000$-558,000$-360,000$-1,254,000
    Net Income$35.66M$15.71M$-491,000$28.32M$-38,482,000$7.72M$43.94M$7.32M$-8,759,000$-2,484,000$-45,027,000$-1,772,000
    EBITDA$30.27M$13.01M$-18,288,000$18.80M$-43,802,000$443,000$69.08M$-36,746,000$-23,788,000$-17,004,000$-59,300,000$-15,128,000
    EBIT$26.90M$9.29M$-21,945,000$15.26M$-48,004,000$-2,397,000$66.55M$-40,313,000$-25,301,000$-18,735,000$-60,477,000$-17,276,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CRON

    News

    Cronos Group (NASDAQ:CRON) Stays In Focus As Cannabis Reform Moves Forward

    Cronos Group (NASDAQ:CRON) is gaining attention as federal cannabis rescheduling to Schedule III advances, which is expected to ease tax burdens and reshape the industry. The company stands out due to its strong cash reserves, disciplined approach, and a product mix that includes growing edibles and derivative products, aligning with evolving consumer tastes. This reform, combined with Cronos's strategic positioning, keeps it central to the cannabis sector's ongoing transformation.

    Kalkine Media•9/1/26•
    Bullish

    Pillsbury Lake Capital LLC Invests $2.25 Million in Cronos Group Inc. $CRON

    Pillsbury Lake Capital LLC has invested approximately $2.25 million in Cronos Group Inc. by acquiring 810,163 shares, representing a 0.22% stake. This investment highlights continued institutional interest in Cronos Group, with hedge funds and institutions collectively owning 8.71% of the company. Analysts hold a "Moderate Buy" rating for Cronos Group, which recently exceeded Q2 earnings and revenue expectations, and its shares are trading near a 52-week high.

    MarketBeat•8/28/26•
    Bullish

    Cibc World Market Inc. Invests $3.82 Million in Cronos Group Inc. $CRON

    CIBC World Markets Inc. has significantly increased its stake in Cronos Group Inc. (NASDAQ:CRON) by acquiring 1.38 million shares valued at approximately $3.82 million during the second quarter of 2026. This investment gives CIBC World Markets a 0.37% ownership in the company. Despite mixed analyst ratings, with a consensus "Hold" and an average price target of $2.30, Cronos Group recently exceeded Q2 earnings expectations, reporting $0.09 EPS against estimates of $0.01 and revenues of $53.01 million compared to $44.20 million expected.

    MarketBeat•8/27/26•
    Somewhat-Bullish

    Cronos Group Inc. stock rises Tuesday, outperforms market

    Cronos Group Inc. (CRON) stock increased by 2.93% on Tuesday, closing at $3.51. This performance outpaced the broader market, as both the NASDAQ Composite Index and the Dow Jones Industrial Average also saw gains. This marks the third consecutive day of gains for Cronos Group stock.

    MarketWatch•8/25/26•
    Bullish

    Cronos Group Inc (TSX:CRON) Advances Higher as Global Cannabis Expansion and Improving Financial Performance Strengthen Market Sentiment

    Cronos Group Inc (TSX:CRON) saw a 3.49% increase in its share price on August 24, 2026, driven by improved investor sentiment towards the cannabis sector and the company's strengthening financial performance. The company's strategic focus on expanding its branded cannabis products internationally, improving operational efficiency, and disciplined capital management has contributed to this positive market view. While the cannabis industry still faces regulatory and competitive risks, Cronos's global footprint and efforts towards profitability position it for potential future growth.

    kalkine.ca•8/25/26•
    Bullish

    Frequently Asked Questions About CRON

    Does CRON pay dividends?
    Cronos Group Inc (CRON) does not currently pay a regular dividend.
    What is CRON's P/E ratio?
    Cronos Group Inc has a price-to-earnings (P/E) ratio of 19.22.
    What is CRON's market cap?
    Cronos Group Inc (CRON) has a market capitalization of $1.24B with a current stock price of $3.37.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In